Skip to main content
. Author manuscript; available in PMC: 2018 Jan 5.
Published in final edited form as: Vaccine. 2015 Jan 28;33(12):1492–1498. doi: 10.1016/j.vaccine.2015.01.043

Table 2.

Serogroup A meningococcal (PsA-TT) conjugate vaccine and measles-containing vaccine (MCV) vaccination coverage rates by region and age group.

Region PsA-TT
MCV
2–5 years
6–15 years
16–30 years
12–23 months
% 95% CI % 95% CI % 95% CI % 95% CI
Boucle du Mouhoun 96.4 92.5–98.3 97.7 94.1–99.1 93.3 87.1–96.7 94.9 88.6–97.8
Cascades 97.8 93.9–99.2 98.5 96.6–99.4 97.8 95.2–99.0 95.4 88.7–98.2
Centre 93.5 88.0–96.6 93.9 88.6–96.9 87.1 80.2–91.9 93.3 83.0–97.6
Centre-Est 99.2 97.8–99.7 98.9 96.7–99.7 96.4 94.2–97.8 95.6 90.1–98.1
Centre-Nord 98.1 95.9–99.1 98.9 96.8–99.6 93.3 89.9–95.6 92.8 85.8–96.5
Centre-Ouest 98.6 96.0–99.5 99.0 97.8–99.6 96.7 94.6–98.1 94.9 88.1–97.9
Centre-Sud 99.1 97.3–99.7 99.0 97.0–99.7 96.1 92.5–98.1 95.7 87.0–98.7
Est 96.2 91.0–98.4 95.4 89.5–98.1 92.8 85.3–96.7 92.1 85.6–95.7
Hauts-Bassins 97.0 90.5–99.1 98.4 94.8–99.5 94.6 91.0–96.9 96.3 90.4–98.7
Nord 98.0 96.2–99.0 97.9 95.9–99.0 95.8 92.8–97.6 95.2 88.0–98.2
Plateau Central 97.1 94.7–98.5 97.9 96.2–98.9 93.9 90.5–96.2 92.9 86.4–96.4
Sahel 95.6 91.1–97.9 95.6 92.0–97.6 93.0 89.0–95.6 75.3 58.8–91.8
Sud-Ouest 96.7 91.7–98.8 96.3 91.6–98.4 94.8 87.3–97.9 82.6 69.9–90.7
Burkina Faso 97.0 96.1–97.8 97.4 96.6–98.0 93.4 91.9–94.6 92.5 90.5–94.1